Over the past several weeks, our advocacy efforts in Washington have been strong and, in some cases, effective. We’ve seen congressional pushback on proposed NIH budget cuts, bipartisan calls to release delayed appropriated funds (Senate letter to OMB), and movement to protect negotiated indirect cost rates at agencies like NIH, NSF, DOE, and DoD. These steps reflect recognition on Capitol Hill that federally funded research drives innovation, creates jobs, and delivers solutions that benefit the public.
At the same time, the federal funding landscape continues to evolve. Last week’s Executive Order introduces sweeping changes to the grantmaking process, including:
- Freezing new funding opportunities until additional review processes are in place.
- Preferential treatment for lower indirect cost rates in certain discretionary awards.
- Expanded authority to terminate discretionary grants; including existing awards, if they no longer align with agency priorities or the “national interest.”
- Further limits on allowable facilities and administrative (F&A) costs for discretionary grants.
The White House fact sheet provides more detail on these changes. While the full implementation timeline and impact are not yet clear, they could affect how we compete for and manage federal awards.
What You Can Do Now:
- Watch for updated agency guidance and terms in new or amended awards.
- Reach out to the Office of Sponsored Projects (OSP) with questions about how these changes may affect your funding.
Our research community has a long history of adapting to change, and this moment is no different. We remain engaged with our national associations and Utah’s congressional delegation to ensure your work, and the societal impact it delivers, remains visible and valued.
We will continue to share updates and guidance as details emerge.
Erin Rothwell, PhD
Vice President for Research
